Operations
bluebird bio Provides Update on Severe Genetic Disease Programs and Business Operations
bluebird bio, Inc.
PR-M04-21-027Apr 26, 2021
Drug Pricing
High Price of Zynteglo (LentiGlobin) Impacts Bluebird’s Stock Price
Nice Insight
PAO-M06-19-NI-022Jun 21, 2019
Collaboration
Regeneron and bluebird bio Announce Collaboration to Discover, Develop and Commercialize New Cell Therapies for Cancer
Regeneron
PR-M08-18-NI-054Aug 14, 2018
Immunotherapy
Medigene, Bluebird Bio Collaboration on TCR Immunotherapy Extended
Guy Tiene
Nice Insight
PAO-M05-18-NI-010May 17, 2018
CAR-T
bluebird bio and Celgene Corporation Enter into Agreement to Co-Develop and Co-Promote Anti-BCMA CAR T Cell Therapy bb2121 in the United States
bluebird bio, Inc.
PR-M03-18-NI-107Mar 30, 2018